A Study of SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Clinical trial NCT05681819 · COMPLETED

Trial details

NCT number: NCT05681819
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2023-02-17
Primary completion: 2024-05-18
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.